Mutant p53 Protects Triple-Negative Breast Adenocarcinomas from Ferroptosis In Vivo

Investigators used an autochthonous somatic TNBC mouse model, in which mutant p53 could be toggled on and off genetically while leaving the tumor microenvironment intact and wild-type for p53 to identify physiological dependencies on mutant p53.